z-logo
open-access-imgOpen Access
Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity
Author(s) -
Stefan Lutz,
Andreas Peter,
Fausto Machicao,
Apostolia Lamprinou,
Jürgen Machann,
Fritz Schick,
Ingmar Königsrainer,
Alfred Königsrainer,
Andreas Fritsche,
Harald Staiger,
HansUlrich Häring,
Norbert Stefan,
Kοnstantinos Kantartzis
Publication year - 2016
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-2498
Subject(s) - single nucleotide polymorphism , endocrinology , medicine , minor allele frequency , insulin resistance , nonalcoholic fatty liver disease , 11β hydroxysteroid dehydrogenase type 1 , allele , odds ratio , intra abdominal fat , obesity , biology , fatty liver , genotype , gene , genetics , disease , dehydrogenase , enzyme , biochemistry , visceral fat
Acute pharmacological inhibition of 11β-hydroxysteroid-dehydrogenase 1 (11β-HSD1), which converts cortisone into the much more potent cortisol in peripheral tissues, results in reduction of total, visceral, and liver fat but not insulin resistance. We now investigated whether lifelong alterations of 11β-HSD1 activity similarly affect these cardiometabolic risk parameters by studying single-nucleotide polymorphisms (SNPs) in the 11β-HSD1-coding gene (HSD11B1).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom